Kayvon Modjarrad

InstitutionWalter Reed Army Institute of Research
AddressSilver Spring
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 1 publications in April 2020 and July 2020 and August 2020 and June 2021 and August 2021 and Spetember 2021
    All Publications
    Bar chart showing 53 publications over 18 distinct years, with a maximum of 10 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Citations: 4     Fields:    Translation:AnimalsCells
    2. Pollett S, Conte MA, Sanborn M, Jarman RG, Lidl GM, Modjarrad K, Maljkovic Berry I. A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic. Sci Rep. 2021 08 30; 11(1):17365. PMID: 34462471.
      Citations: 1     Fields:    Translation:HumansCells
    3. Chaudhury S, Hutter J, Bolton JS, Hakre S, Mose E, Wooten A, O'Connell W, Hudak J, Krebs SJ, Darden JM, Regules JA, Murray CK, Modjarrad K, Scott P, Peel S, Bergmann-Leitner ES. Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform. PLoS One. 2021; 16(6):e0252628. PMID: 34081747.
      Citations: 5     Fields:    Translation:HumansCells
    4. Dearlove B, Lewitus E, Bai H, Li Y, Reeves DB, Joyce MG, Scott PT, Amare MF, Vasan S, Michael NL, Modjarrad K, Rolland M. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23652-23662. PMID: 32868447.
      Citations: 73     Fields:    Translation:HumansCellsPHPublic Health
    5. Joyce MG, Wheatley AK, Modjarrad K. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks. Cell. 2020 07 09; 182(1):7-9. PMID: 32649880.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    6. Modjarrad K, Kim JH. Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? Lancet Infect Dis. 2020 07; 20(7):760-761. PMID: 32325036.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    7. Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K, Reuschel EL, Robb ML, Racine T, Oh MD, Lamarre C, Zaidi FI, Boyer J, Kudchodkar SB, Jeong M, Darden JM, Park YK, Scott PT, Remigio C, Parikh AP, Wise MC, Patel A, Duperret EK, Kim KY, Choi H, White S, Bagarazzi M, May JM, Kane D, Lee H, Kobinger G, Michael NL, Weiner DB, Thomas SJ, Maslow JN. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Lancet Infect Dis. 2019 09; 19(9):1013-1022. PMID: 31351922.
      Citations: 108     Fields:    Translation:HumansCellsCTClinical Trials
    8. Adney DR, Wang L, van Doremalen N, Shi W, Zhang Y, Kong WP, Miller MR, Bushmaker T, Scott D, de Wit E, Modjarrad K, Petrovsky N, Graham BS, Bowen RA, Munster VJ. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas. Viruses. 2019 03 02; 11(3). PMID: 30832356.
      Citations: 31     Fields:    Translation:AnimalsCells
    9. Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, Saunders KO, Tatti KM, Haynes LM, Kwong PD, Modjarrad K, Kong WP, McLellan JS, Denison MR, Munster VJ, Mascola JR, Graham BS. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape. J Virol. 2018 05 15; 92(10). PMID: 29514901.
      Citations: 75     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Excler JL, Delvecchio CJ, Wiley RE, Williams M, Yoon IK, Modjarrad K, Boujelal M, Moorthy VS, Hersi AS, Kim JH. Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015. Emerg Infect Dis. 2016 08; 22(8). PMID: 27439020.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    11. Modjarrad K, Moorthy VS, Ben Embarek P, Van Kerkhove M, Kim J, Kieny MP. A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation. Nat Med. 2016 07 07; 22(7):701-5. PMID: 27387881.
      Citations: 28     Fields:    Translation:HumansCells
    12. Modjarrad K. MERS-CoV vaccine candidates in development: The current landscape. Vaccine. 2016 06 03; 34(26):2982-2987. PMID: 27083424.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    13. Modjarrad K. Treatment strategies for Middle East respiratory syndrome coronavirus. J Virus Erad. 2016; 2(1):1-4. PMID: 26866060.
      Citations: 14     
    14. Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015; 4:709. PMID: 26618098.
      Citations: 82     
    15. Kilianski A, Nuzzo JB, Modjarrad K. Gain-of-Function Research and the Relevance to Clinical Practice. J Infect Dis. 2016 May 01; 213(9):1364-9. PMID: 26416657.
      Citations: 6     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    16. Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, Johnson JC, Olinger G, Todd JP, Bagci U, Solomon J, Mollura DJ, Hensley L, Jahrling P, Denison MR, Rao SS, Subbarao K, Kwong PD, Mascola JR, Kong WP, Graham BS. Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015 Jul 28; 6:7712. PMID: 26218507.
      Citations: 138     Fields:    Translation:HumansAnimalsCells